MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in managing stress and navigating identity, information, family, DNA-testing, and donor- or sibling-contact-related experiences.
This randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control group. The primary objectives are to assess recruitment, retention, intervention uptake and completion, data completeness, acceptability, usability, and potential unwanted effects. Changes in perceived stress, psychological wellbeing, coping, and donor-conception-related identity will be explored to assess the suitability and variability of outcome measures and to inform the design of a future trial.
Donor-conceived people
Aged 18 or over
Able to read and understand English
Provide informed consent
Not donor-conceived
Underaged ot minor
Unable to read and understand English
Unable to provide informed consent
Parallel
MyGENESIS Digital Psychoeducational Program
BehavioralA self-guided digital psychoeducational intervention based on cognitive-behavioral principles and the transactional model of stress.
Perceived stress
Change in perceived stress (PSS-4) total score (range 0-40, higher scores indicating greater perceived stress)
Psychological well-being
Change in the WHO well-being index (WHO-5) total score (range 0-40, higher scores indicating greater well-being )
Coping
Change in coping responses as measured by the Brief COPE Inventory subscale scores (14 subscales, each ranging from 2-8, with higher scores indicating greater use of the respective coping strategy)
Donor-conception identity
Change in donor conception identity as measured by the Donor Conception Identity Questionnaire (DCIQ) subscale scores, including Concern and Preoccupation (range 8-40), Internalized Stigma (range 5-25), Pride and Acceptance (range 6-30), and Openness and Understanding (range 4-20) Higher scores indicate greater endorsement of the respective donor conception identity domain.
Click on the lead sponsor to view all of their trials.
Universidade do Porto
Lead sponsor
Fundação para a Ciência e a Tecnologia
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
